Tag Archives: statins

Statin benefits in primary prevention outweigh risk of diabetes

The benefit of preventing vascular events outweighs the increased risk of new-onset diabetes in patients without cardiovascular disease but with an elevated level of high-sensitivity C-reactive protein (hs-CRP), researchers have found. India is the country with the greatest number of diabetes patients in the world, according to the International Diabetes… 

Read more »
Posted in Cardiovascular, Diabetes, Non-Communicable Disease, Non-Communicable Disease Featured 2, Primary Care | Also tagged , , , , , , , , , | Volume: | 2 Responses

Widespread use of statins for primary prevention could reduce risk of vascular events

Even patients with a 5-year risk for major vascular events <10% may benefit from primary prevention using statin therapy, according to the results of a large meta-analysis. This study may hold particular significance for patients in India, where genetic susceptibility results in a higher rate of vascular events, and where… 

Read more »
Posted in Cardiovascular, Non-Communicable Disease, Non-Communicable Disease Featured 2, Primary Care | Also tagged , , , , , , , , , , | Volume: | 1 Response

Statin use may have a protective effect against pneumonia mortality

A new meta-analysis has found that although statin use is associated with decreased mortality after pneumonia, this effect is weaker in certain subgroups. Statins may have positive effects on inflammation, which is the hallmark feature of pneumonia. Key Point: This new meta-analysis found that statin use is associated with decreased… 

Read more »
Posted in Cardiovascular, Infectious Disease, Primary Care | Also tagged , , , , , , | Volume: | Leave a comment

Polypill may help prevent cardiovascular disease in patients 50 years and older

Researchers have found that so-called cardiovascular “polypills” may be effective as primary therapy to prevent cardiovascular disease (CVD) in patients aged 50 years and older. “This is an important study but should not be considered as proof of concept, as the authors themselves have acknowledged several limitations, including lack of… 

Read more »
Posted in Cardiovascular, Primary Care | Also tagged , , , , , , , , , , , , , , , , , , , , , | Volume: | 1 Response

Statins may slow knee OA, but no effect seen at the hip

Statin use may slow the progression of osteoarthritis (OA) of the knee but does not appear to affect the rate of OA progression in the hip, according to a recently published prospective observational study. For the analysis, x-rays of the hip and knee were examined at baseline and again an… 

Read more »
Posted in Geriatrics, Orthopedics, Pharmacology, Primary Care | Also tagged , , , , , , , , | Volume: | Leave a comment

Protection against Parkinson disease could be an added benefit of statins

An added benefit from statin use appears to be a slightly lower risk of Parkinson disease (PD), according to an analysis of 2 large prospective cohorts. Key Point: Statin use may offer moderate protection against the development of Parkinson disease, but further studies are needed to confirm this association. The… 

Read more »
Posted in Neurology, Pharmacology | Also tagged , , | Volume: | Leave a comment

Rheumatoid arthritis patients who stop statin therapy have higher risk of death

Patients with rheumatoid arthritis (RA) who discontinue their statin therapy increase their risk of dying from cardiovascular disease and other causes, according to the findings of a population-based study. Patients with RA should therefore be advised of the importance of compliance to their statin therapy, the study authors advised. The… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Pharmacology | Also tagged , , , , , , , | Volume: | Leave a comment